Advertisements

Paracetamol Galpharm

Quick links to important sections

Paracetamol Galpharm

Advertisements

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Paracetamol Galpharm

Paracetamol Galpharm is an over-the-counter (OTC) medicinal product used for the symptomatic relief of mild to moderate pain and fever. This medicine is defined by its single-ingredient composition and its classification as both an analgesic and an antipyretic.


Quick Facts

Property Description
Active ingredient Paracetamol (Acetaminophen)
Form Oral tablet or capsule (Caplet)
Pharmacological class Analgesic, Antipyretic
Common use Pain relief, Fever reduction
Origin Synthetic chemical compound

What Type of Medicine is Paracetamol Galpharm? (Classification and Identity)

Paracetamol Galpharm is classified as a Non-opioid analgesic and is recognized for its dual action as an analgesic (pain reliever) and an antipyretic (fever reducer). The active substance, Paracetamol, is a well-established medicine used for treating pain and fever. The medicine's use is clinically recognized for its efficacy in reducing discomfort and elevated body temperature. It is a synthetic compound, chemically distinct from the Non-steroidal Anti-inflammatory Drugs (NSAIDs), as it does not produce significant peripheral anti-inflammatory effects.


Composition and Available Forms (Component and Presentation)

The therapeutic effect is derived solely from the Active ingredient, Paracetamol, which is scientifically equivalent to Acetaminophen (C8H9NO2). Paracetamol Galpharm is typically presented as an Oral tablet or Oral capsule (Caplet), a solid form designed for Oral administration and systemic action. Paracetamol is one of the most frequently used analgesic and antipyretic drugs and is considered a first-line treatment for pain and fever. The availability of this preparation as a standard oral tablet allows for its typical use by adults and older children for managing general aches or cold-related fevers.


General Purpose and Core Benefits (High-Level Symptomatic Relief)

The general purpose of Paracetamol Galpharm is to provide effective symptomatic relief by achieving pain relief and fever reduction. The medicine acts centrally, affecting the nervous system to elevate the body's pain threshold and regulate temperature during a fever. This mechanism ensures the core benefit is focused relief from common mild to moderate aches and elevated body temperature, without treating the underlying condition.

Advertisements

What side effects are possible with Paracetamol Galpharm?

Possible side effects and safety information

The safety profile of the active substance, paracetamol (acetaminophen), is primarily characterized by the officially documented adverse reactions and safety constraints established in regulatory labeling.

Official Adverse Reactions and Classification

Adverse effects are officially categorized by their frequency and the system-organ-class they affect. The majority of serious adverse reactions are classified as Rare or Very Rare in standard therapeutic use, indicating they affect less than 1 in 1,000 users.

Classification System-Organ Class Examples
Rare Increases in hepatic transaminases; Hypersensitivity reactions.
Very Rare Serious Blood Dyscrasias (e.g., Thrombocytopenia, Agranulocytosis); Severe Skin Reactions (e.g., SJS, TEN).

Serious Adverse Reactions and Safety Constraints

The most significant safety concern documented in regulatory texts is the risk of Severe Hepatic Injury and Liver Failure. This risk is explicitly linked to exceeding the recommended dose. Regulators state that the dose limit must not be surpassed, as this is the primary cause of severe toxicity.

Other documented serious risks include Severe Cutaneous Adverse Reactions (SCARs), such as Stevens-Johnson Syndrome (SJS), and systemic Anaphylactic Reactions affecting the immune system.

Population-Specific and Duration-Related Safety

Official labeling advises specific caution for individuals with severe hepatic impairment or those who are at risk of glutathione depletion (e.g., severe malnutrition or chronic alcoholism). The elimination of the substance is also a factor in severe renal impairment.

Safety notes tied to duration state that chronic regular use of the medicine may potentiate the effect of anticoagulant medicines. Furthermore, prolonged and high-dose use of analgesics is associated with a risk of permanent renal damage, known as analgesic nephropathy.

Advertisements

Overdose and Emergency Response

Overdose with Paracetamol (Acetaminophen) is officially documented to carry a serious, life-threatening risk, primarily leading to fulminant hepatic failure and potential death. The government-stated guidance is to seek immediate medical attention or contact emergency services right away for any suspected overdose. This action is mandatory regardless of the presence of symptoms, as the most severe consequences can be delayed.

Initial, non-specific manifestations of overdose often include nausea, vomiting, and abdominal pain. As toxicity progresses, official labeling notes the potential for jaundice, coagulation defects, and the development of acute kidney failure. Patients with underlying liver disease or chronic alcohol misuse are noted in regulatory information as having an increased susceptibility to severe hepatotoxicity.

The specific antidote for Paracetamol overdose is N-acetylcysteine (NAC). Regulatory sources emphasize that immediate hospital monitoring is required, and the antidote's effectiveness in preventing severe liver damage is highly time-dependent. Management protocols necessitate monitoring of serum Paracetamol concentration and liver function tests to guide treatment.

Advertisements

Therapeutic Uses of Paracetamol Galpharm

Quick Facts: Primary Therapeutic Areas

  • Symptom Management: Supports the management of mild to moderate pain.
  • Fever Reduction: Aids in reducing high body temperature (fever).
  • Pain Domains: A recognized option for temporary relief of headaches, dental discomfort, and menstrual pain.

Paracetamol Galpharm is an accessible medication indicated for providing temporary, symptomatic relief from a variety of common conditions. Its primary function is to support the management of mild to moderate pain and to aid in the reduction of feverishness and elevated body temperature.

This medication is commonly utilized for discomforts such as tension headaches, migraines, and toothache. It may also offer support for nerve pain (neuralgia), sore throat, and period pains. Furthermore, it is a suitable option for addressing aches associated with colds and influenza, as well as joint and muscle discomfort, including lumbago, rheumatic pain, and sciatica.

Regulatory References

  1. NIH MedlinePlus guidance
Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Paracetamol Galpharm?

This section describes the population eligibility and non-eligibility rules for Paracetamol Galpharm (500 mg tablets/caplets), as defined in official governmental regulatory documentation.


Contraindications and Restrictions

Classification Population Group/Condition
Absolute Contraindication Patients with known hypersensitivity or allergic reaction to paracetamol or any excipients.
Not Recommended Children under 6 years of age (for the 500 mg tablet strength).
Use With Caution Individuals with severe renal impairment, severe hepatic impairment, chronic alcoholism, malnutrition, or G6PD deficiency.

Age-Specific Eligibility

Paracetamol 500 mg tablets are officially permitted for use by adults and adolescents (16 years and older) under standard labeled conditions. Use is also permitted for children aged 6 to 15 years with appropriate consideration for dose. Dosage adjustment or medical consultation is advised for individuals with organ function constraints, such as severe kidney or liver insufficiency.

Pregnancy and Lactation

Regulatory labeling states that paracetamol may be used during pregnancy if clinically needed, provided the lowest effective dose is administered for the shortest necessary duration. Use during breastfeeding is also generally permitted, as the amount excreted in breast milk is not considered clinically significant.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section describes interactions of the active ingredient, Paracetamol (Acetaminophen), as officially documented in regulatory information.

Documented Pharmacokinetic and Metabolic Interactions

Co-administration with other acetaminophen or paracetamol-containing products is formally contraindicated by regulatory agencies due to the significant risk of accidental overdose leading to severe hepatotoxicity. Products that stimulate liver microsomal enzymes, such as anticonvulsant agents and chronic heavy alcohol consumption, increase the documented metabolic risk of liver damage by enhancing the formation of toxic metabolites.

Agents that affect gastric emptying alter the rate of paracetamol absorption. Metoclopramide and Domperidone increase the rate of absorption, while Colestyramine reduces it. To minimize the reduction in exposure caused by Colestyramine, official regulatory guidance requires that the two agents be administered at least one hour apart.

Pharmacodynamic and Outcome Risk

Regular, prolonged use of paracetamol with oral anticoagulants (e.g., Warfarin) is officially documented to increase the anticoagulant effect, thereby elevating the risk of haemorrhage. Furthermore, the combination with Flucloxacillin is associated with a specific risk of High Anion Gap Metabolic Acidosis (HAGMA). This specific risk is noted in official documentation as being heightened in certain populations, including those with severe renal impairment or malnutrition.

Advertisements

Mechanism of Action

Paracetamol acts predominantly within the central nervous system (CNS) through the inhibition of cyclooxygenase (COX) enzymes. The drug's affinity is higher for CNS COX isoforms compared to those in peripheral tissues. This localized enzymatic inhibition restricts the metabolic conversion of arachidonic acid, leading to a diminished biosynthesis of prostanoids. Specifically, the intracellular reduction of prostaglandin E₂ (PGE2) levels is a key consequence. PGE2 functions as a crucial molecular mediator in the signal transduction pathways associated with nociception and thermoregulation. The resulting reduction in PGE2 concentration modifies the activity within the thermoregulatory center of the hypothalamus, alongside the modulation of central signaling involved in afferent sensory pathways.

Advertisements

Dosage and Administration Information

Official Administration Guidelines

The correct use of Paracetamol Galpharm (a 500 mg oral tablet or caplet) is governed by specific instructions to ensure proper administration. This section details the dosing and procedural rules.

Usage Constraint Standard Dosing Protocol (Adults and Adolescents ge 50 kg)
Route of Administration Oral use only. Tablets must be swallowed whole with water.
Single Dose Range 500 mg to 1,000 mg (1 to 2 tablets).
Minimum Dosing Interval A minimum of 4 hours must be maintained between doses.
Maximum Total Daily Dose The total quantity must not exceed 4,000 mg in a 24-hour period.
Duration of Use Intended for short-term administration. Use should not exceed 3 days without consulting a health professional.

Administration Conditions and Special Rules

The medicine may be taken with or without food. If taken on an empty stomach, the rate of absorption may be accelerated, but not the intensity of the effect. Crucially, Paracetamol Galpharm must not be taken concurrently with any other product that contains the active ingredient Paracetamol (Acetaminophen) to avoid exceeding the maximum daily limit.

Dosing Adjustments: Standard clinical practice indicates that the dosing regimen requires modification for specific populations. Patients with severe renal or hepatic impairment typically require a reduction in the total daily dose or an extension of the dosing interval (e.g., to 6 or 8 hours). Similarly, for adults weighing less than 50 kg, the maximum total daily dose may be typically limited to 3,000 mg.

This structured protocol defines the standardized, label-based approach for using the product, focusing exclusively on adherence to the prescribed route, dose limits, and timing intervals.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Paracetamol Galpharm


Evidence for Use in Mild to Moderate Pain Relief

Research has extensively studied the use of paracetamol (the active ingredient in Paracetamol Galpharm) in contexts involving various types of physical discomfort. The evidence base includes many Randomized Controlled Trials (RCTs), along with Systematic Reviews that combine data from numerous individual studies. Research was studied for its application in trials assessing outcomes related to physical discomfort.

The studies examined outcomes related to physical discomfort in various conditions characterized by fluctuating or episodic manifestations, such as certain types of headaches and conditions marked by functional limitations (e.g., musculoskeletal discomfort). Evidence describes that in some specific conditions, findings were observed in some studies where measured pain intensity patterns differed from placebo. However, for a broad range of other mild-to-moderate aches, the consistency of findings remains limited and heterogeneous.


Evidence for Use in Fever Reduction (Antipyretic Action)

The antipyretic action of paracetamol was studied for its impact on elevated body temperature, which is an outcomes related to systemic or functional imbalance. Controlled clinical trials and RCTs research examined how quickly and to what degree the active ingredient can affect temperature during an episode of fever.

Studies monitored core body temperature change over defined time intervals, typically observing responses over defined time intervals lasting a few hours. This research describes patterns where the substance was observed in relation to changes in elevated body temperature across various age groups. The evidence contributes to the broader evidence landscape by showing patterns related to the acute effects on temperature during a temporary physiological imbalance.


Long-Term Studies and Follow-up

Research has been studied for potential effects over different timeframes. For conditions where symptoms may vary in intensity over an extended period, such as osteoarthritis, research has explored outcomes that included follow-up periods lasting up to two years. However, outside of these chronic condition studies, there is limited information for long-term outcomes regarding the general, intermittent use of the medicine.


Evidence in Special Populations

Specific research was evaluated in certain populations, including those where physiological factors can affect how medicines are processed. Specifically, studies research describes the patterns of use in older children and adolescents and how the substance was studied for fever research exploring short-term symptom changes in these groups. Regulatory reviews research examined the available data for pregnant individuals.


What is Still Uncertain About Paracetamol Galpharm

Research helps contextualize how patients reported their experience and highlights what is known — and what is still uncertain. Key limitations noted in the research landscape include that the evidence quality varies across studies, leading to findings were mixed when comparing different pain types. Furthermore, many studies are characterized by modest sample sizes, and follow-up durations were limited, meaning the results apply only to the populations studied and for the specific time interval examined.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Paracetamol Galpharm (FAQ)


Q: How quickly can I expect Paracetamol Galpharm to start working?

Official product information, based on pharmacokinetic studies, indicates that the active ingredient is readily absorbed from the digestive system. Peak concentrations of the medicine in the blood are typically reached within 10 to 60 minutes after taking it orally.


Q: How long does the effect of Paracetamol Galpharm typically last?

The official documents describe the elimination half-life of the active ingredient, which is a measure used to describe how quickly the substance is cleared from the body. This half-life typically ranges from approximately 1 to 3 hours in adults.


Q: What are the most commonly reported side effects of Paracetamol Galpharm?

According to official regulatory safety profiles, adverse effects are primarily classified as Rare or Very Rare when used as directed. Documented reactions include general skin rashes or hypersensitivity reactions. Very rare, but serious, documented effects involve blood disorders or severe skin reactions.


Q: What ingredients are in Paracetamol Galpharm besides the active component?

All tablets contain the active ingredient paracetamol, along with various inactive ingredients, known as excipients. Specific excipients, such as sodium metabisulphite in some formulations, are listed in detail in the official patient information leaflets.


Q: Are there any reported interactions between Paracetamol Galpharm and alcohol?

Regulatory warnings highlight that chronic heavy alcohol consumption is documented to increase the metabolic risk of liver damage. This is due to the potential for enhanced formation of toxic breakdown products from the medicine in the body.


Q: Are there any known interactions with common prescription blood thinners?

Official sources note that the regular, prolonged use of the medicine, when combined with certain oral anticoagulants (medications to thin the blood, like Warfarin), is documented to increase the anticoagulant effect. This combination elevates the documented risk of bleeding (haemorrhage).


Q: What are the main risks described in official documents regarding long-term use?

The documented risks associated with chronic regular use include two main concerns. One is the potentiation of the effect of anticoagulant medicines. The other is that high-dose, prolonged use is associated with a risk of permanent renal damage, known as analgesic nephropathy.


Q: How does the body break down and eliminate Paracetamol Galpharm?

The active substance is processed and changed primarily in the liver. Once metabolized, it is then mostly eliminated from the body in the urine. Very little of the original, unchanged drug is excreted this way.


Q: Is there a different way Paracetamol Galpharm works compared to NSAIDs?

Yes, the active ingredient is chemically separate from Non-steroidal Anti-inflammatory Drugs (NSAIDs). The official description of its action is thought to be through the central inhibition of prostaglandin synthesis in the brain, which differs from the significant peripheral anti-inflammatory effects produced by NSAIDs.


Q: Is Paracetamol Galpharm safe for children, or is a specific product needed?

Official guidance indicates that the 500 mg strength tablet is typically intended for use in individuals aged 6 years and older, with dose adjustments. Official documents describe the existence of other specific strengths and liquid formulations that are designed for use by younger age groups.


Q: Does Paracetamol Galpharm come in different strengths or formulations?

According to official documentation, the active ingredient is described as being available in multiple dosage forms and strengths. These typically include tablets, capsules, and oral liquids at various concentrations.


Q: What is meant by 'contraindication' when discussing Paracetamol Galpharm?

A contraindication is a term used in regulatory documents to describe a specific condition or situation where a medicine must not be used. For Paracetamol Galpharm, an example is a known allergy to the medicine or any of its inactive ingredients.


Q: Can Paracetamol Galpharm affect the results of any medical lab tests?

Clinical literature includes reports noting that the active ingredient may sometimes cause an increase in laboratory markers such as certain liver enzymes, including alkaline phosphatase and bilirubin.


Q: Are there different storage requirements for Paracetamol Galpharm liquid versus tablets?

Official storage instructions require that the medicine be kept out of the sight and reach of children and protected from moisture and light. While specific temperature limits vary, different requirements are sometimes noted for liquid suspensions compared to solid forms.


Q: Can Paracetamol Galpharm be used for chronic pain conditions?

Regulatory documents focus on short-term administration, which is defined by a maximum duration of use that should not be exceeded. While the active ingredient is studied for some chronic conditions, its general use is described as symptomatic relief for acute pain and fever.


Q: Does Paracetamol Galpharm interact with common anti-nausea medications?

Yes, official documents describe an interaction where the rate at which the active ingredient is absorbed may be accelerated by medicines that increase gastric emptying. These include anti-nausea medications such as metoclopramide and domperidone.


Q: Are there studies examining Paracetamol Galpharm's use in combination with caffeine?

Official product assessments for combined medicines document the use of the active ingredient together with caffeine. These assessments confirm that such products are authorized and considered therapeutically appropriate.


Q: Do official patient information leaflets include specific warnings for drivers?

Official patient information leaflets typically include a specific section detailing the effect on the ability to drive and use machines. For the single ingredient product, this section usually confirms that no adverse effect is expected when the medicine is taken at the recommended dose.


Q: Is Paracetamol Galpharm generally considered non-addictive?

The regulatory classification system lists this medicine under the Anilides subgroup of Other Analgesics. This classification is chemically distinct from opioid analgesics, which are associated with a different risk profile for dependence.


Q: How is the safety of Paracetamol Galpharm monitored after it is released to the public?

Safety is continuously monitored by government bodies through pharmacovigilance systems. These systems allow both health professionals and the public to report any suspected side effects to the regulatory agency for evaluation.


Q: What is the main difference between Galpharm and other brands of paracetamol?

The active ingredient (paracetamol) is chemically identical across all brands, including Galpharm. Regulatory and scientific studies generally confirm that generic products are bioequivalent to brand-name products, meaning they are expected to have the same effects and risks.


Q: Is it common to feel sleepy or drowsy after taking Paracetamol Galpharm?

While the single-ingredient product does not typically list drowsiness as a common side effect in regulatory documents, some studies examining combination products that include paracetamol have occasionally reported sleepiness or drowsiness.


Q: Can Paracetamol Galpharm interact with herbal supplements?

Official advice generally recommends informing a health professional about all other medicines, including herbal remedies or supplements. This is because many herbal products are not subjected to the same formal testing for drug interactions as prescribed or pharmacy medicines.


Q: Are there any long-term health concerns associated with using Paracetamol Galpharm?

Public health bodies emphasize using the lowest effective dose for the shortest necessary duration. In addition to the specific risks of nephropathy and anticoagulant potentiation, some research highlights the need to raise awareness about the potential negative effects associated with excessive, prolonged use.


Q: Does Paracetamol Galpharm expire, and does it lose its potency after the expiration date?

Official labeling states the product must not be used after the expiry date shown on the carton. This date marks the end of the period during which the manufacturer guarantees the full potency and safety of the medication when it has been stored under the correct conditions.


Q: Are there any known interactions with common antidepressant medications?

Standard regulatory interaction screening often indicates that no direct interaction has been formally documented between the active ingredient and many common antidepressant medications. A health professional should always be informed about concurrent use of any other medication.


Q: Is it normal to feel a mild stomach upset after taking paracetamol?

While severe gastrointestinal upset is not listed as a common official side effect, post-marketing reports have occasionally described non-serious adverse events such as nausea or a mild stomach upset in some users.


Q: How is the effect of Paracetamol Galpharm measured in clinical research?

Clinical research measures the effect using specific validated instruments. This typically includes the Visual Analogue Scale (VAS) to objectively assess pain intensity and objective core body temperature readings to assess its fever-reducing action.

Advertisements

How should Paracetamol Galpharm be stored and disposed of?

Storage and Disposal Requirements

This section details the official requirements for storing and disposing of Paracetamol Galpharm, based on regulatory labeling.


Mandatory Conditions

Storage Factor Requirement from Official Labeling
Temperature Store below 25 C or 30 C (maximum varies by license).
Protection Store in the original package to protect from moisture and light.
Child Safety Keep the medicine out of the sight and reach of children.
Disposal Do not discard via wastewater or household waste.

Handling and Stability

The product must not be used after the expiry date shown on the carton. The required storage conditions ensure the medicine remains stable until that date. For disposal, unused or expired medicine must be taken to a pharmacist, who will ensure it is thrown away properly to help protect the environment.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Paracetamol Galpharm found in:

A-Z Index: